Rex is open to discuss the brand new findings and provide his perspective on how the methodology used by Cotton et al. Led to findings differing from those by Pickhardt et al., along with the state of the art of regular colonoscopy and potential future applicability of CT colonography. Dr. Rex commented, This is the third largest study in the literature. Additional research using 2-D imaging had poor results equally. Given these disparate outcomes, we need to observe verification of the results acquired in the Pickhardt research using new methods before CT colonography can be considered as appropriate for colorectal tumor screening.CEM-101 CEM-101 shows a broad spectral range of activity and high potency against respiratory and various other serious pathogens in in vitro and in vivo research. The results from the first Stage 1 dose escalation study demonstrated that doses of CEM-101 from 200 to 600 mg were secure and well tolerated in healthy subjects and that the compound’s pharmacokinetic profile is supportive of once-daily dosing . CEM-101’s in vitro spectrum of activity and potency were examined against a number of respiratory and non-respiratory bacterial pathogens. examined CEM-101 against European medical isolates including S. Aureus, coagulase negative staphylococci, enteroccoci and S.